Quick Answer
NIKA PHARMACEUTICALS, INC reported Cash And Cash Equivalents At Carrying Value of $1.9 thousand for the year ending 2025.
- NIKA PHARMACEUTICALS, INC showed a decrease of -9.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from NIKA PHARMACEUTICALS, INC's annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $1.4 thousand | Q2 2021: $398.00 | Q3 2021: $1.7 thousand | Q4 2021: $399.00 | Q1 2022: $83.00 | Q2 2022: $8.5 thousand | Q3 2022: $3.9 thousand | Q1 2023: $4.5 thousand | Q2 2023: $11.1 thousand | Q3 2023: $10.9 thousand | Q1 2024: $24.5 thousand | Q2 2024: $7.5 thousand | Q3 2024: $1.4 thousand | Q1 2025: $19.1 thousand | Q2 2025: $15.6 thousand | Q3 2025: $6.3 thousand.
- Over the full 6 years of available data (2020 to 2025), NIKA PHARMACEUTICALS, INC's Cash And Cash Equivalents At Carrying Value has grown by 17.3%.
- Historical annual values: Fiscal year 2025: $1.9 thousand | Fiscal year 2024: $2.1 thousand | Fiscal year 2023: $19.6 thousand | Fiscal year 2022: $864.00 | Fiscal year 2021: $399.00 | Fiscal year 2020: $1.6 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: